The primacy of multiparametric MRI in men with suspected prostate cancer.

ABSTRACT:

Background

Multiparametric MRI (mpMRI) became recognised in investigating those with suspected prostate cancer between 2010 and 2012; in the USA, the preventative task force moratorium on PSA screening was a strong catalyst. In a few short years, it has been adopted into daily urological and oncological practice. The pace of clinical uptake, born along by countless papers proclaiming high accuracy in detecting clinically significant prostate cancer, has sparked much debate about the timing of mpMRI within the traditional biopsy-driven clinical pathways. There are strongly held opposing views on using mpMRI as a triage test regarding the need for biopsy and/or guiding the biopsy pattern.

Objective

To review the evidence base and present a position paper on the role of mpMRI i

SUBMITTER: Richenberg J 

PROVIDER: S-EPMC6828624 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature